Evaluación del tratamiento antitrombótico en pacientes geriátricos institucionalizados con fibrilación auricular no valvular

Alaba-Trueba, Javier; Arriola-Manchola, Enrique; Ferro-Uriguen, Alexander; Martínez-Arrechea, Silvia.
Farm. hosp ; 45(4): 170-175, julio-agosto 2021. tab
Artículo en Español | IBECS (España) | ID: ibc-218699

Documentos relacionados

  1. Evaluation of antithrombotic treatment in institutionalized geriatric patients with nonvalvular atrial fibrillation.
  2. In intermediate- or high-risk PE, catheter-directed thrombolysis is linked to reduced mortality vs. systemic thrombolysis or anticoagulation.
  3. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications.
  4. Advances in Nano-Functional Materials in Targeted Thrombolytic Drug Delivery.
  5. Factor Xa inhibitors versus vitamin K antagonist in morbidly obese patients with venous thromboembolism: a systematic review and meta-analysis.
  6. Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease.
  7. Edible Mushrooms as Source of Fibrin(ogen)olytic Enzymes: Comparison between Four Cultivated Species.
  8. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.
  9. Potential clinical applications of phytopharmaceuticals for the in-patient management of coagulopathies in COVID-19.
  10. Improved visual outcomes of central retinal artery occlusion with local intra-arterial fibrinolysis beyond the conventional time window.